PCXX Remin Gel
Natural health product licensed in Canada
- Licence holder
- Ross Healthcare Inc.
- NPN or DIN-HM
- 80023746
- Status
- Active licence
- Licence date
- 11 February 2011
- Revision date
- 13 October 2026
- Form
- Gel
- Route of administration
- Dentaire
- Application type
- TPD Cat IV/LS
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Fluorure de sodium Potency : 0.18 % Flouride Ion | 0.4 % |
Non-medicinal ingredients
Chlorure de sodium, Saccharine, Gomme de xanthane, Benzoate de sodium, Saveur de menthe, Poloxamer, Phosphate de sodium, monobasique, Carbonate de calcium, Sucralose, xylitol, Chlorure de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Gel | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Professional use anticavity treatment.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80023746
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.